Tezer, M., tosun, veysel and Guntekin, U. 2022. Pulmonary Hypertension Secondary to Dasatinib Use for the Treatment of Chronic Myeloid Leukemia: Pulmonary Hypertension Due to Dasatinib Use. International Journal of Current Medical and Biological Sciences. 2, 2 (Jul. 2022), 153–156. DOI:https://doi.org/10.5281/zenodo.6849397.